Product
Sham Treatment
3 clinical trials
7 indications
Indication
KeratoconusIndication
Choroidal MelanomaIndication
Indeterminate LesionsIndication
Uveal melanomaIndication
Ocular melanomaIndication
Diabetic RetinopathyIndication
Diabetic Vitreous HemorrhageClinical trial
A Dose Ranging, Multicenter, Sham-Controlled Study to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects With KeratoconusStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal MelanomaStatus: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
A Randomized, Double-masked, Sham-controlled Study to Evaluate the Efficacy of Peri-operative Farcimab in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic RetinopathyStatus: Not yet recruiting, Estimated PCD: 2025-01-01